日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

KIM-1 as a Biomarker in Genitourinary Neoplasms

KIM-1作为泌尿生殖系统肿瘤的生物标志物

Wang, Wenjia; Liu, Jia-Jun; Li, Yuzhen; Ko, Sungjin; Feng, Ning; Zhang, Manling; Lin, Qingqi; Xia, Mengying; Yu, Yan P; Luo, Jian-Hua; Baldoni, Pedro L; Tseng, George C; Liu, Silvia; Anghelina, Liliana; Radu, Lucrețiu; Trăistaru, Magdalena Rodica; Gheonea, Cristian; Teică, Rossy Vlăduț; Dijmărescu, Anda-Lorena; Anghelina, Adelina-Maria; Camen, Ancuța-Ramona; Guo, Bin; Kafes, Habibe; Ulvan, Nedret; Veros, Christos; Bamias, Aristotelis

IFDlong: an isoform and fusion detector for accurate annotation and quantification of long-read RNA-seq data

IFDlong:一种用于对长读长RNA测序数据进行精确注释和定量分析的异构体和融合检测器

Wang, Wenjia; Li, Yuzhen; Ko, Sungjin; Feng, Ning; Zhang, Manling; Liu, Jia-Jun; Zheng, Songyang; Ren, Baoguo; Yu, Yan P; Luo, Jian-Hua; Tseng, George C; Liu, Silvia

Targeting genomic rearrangements in tumor cells through Cas9-mediated insertion of a suicide gene

通过 Cas9 介导的自杀基因插入,靶向肿瘤细胞中的基因组重排

Chen, Zhang-Hui; Yu, Yan P; Zuo, Ze-Hua; Nelson, Joel B; Michalopoulos, George K; Monga, Satdatshan; Liu, Silvia; Tseng, George; Luo, Jian-Hua

MAN2A1-FER Fusion Gene Is Expressed by Human Liver and Other Tumor Types and Has Oncogenic Activity in Mice

MAN2A1-FER融合基因在人类肝脏和其他肿瘤类型中表达,并在小鼠中具有致癌活性。

Chen, Zhang-Hui; Yu, Yan P; Tao, Junyan; Liu, Silvia; Tseng, George; Nalesnik, Michael; Hamilton, Ronald; Bhargava, Rohit; Nelson, Joel B; Pennathur, Arjun; Monga, Satdarshan P; Luketich, James D; Michalopoulos, George K; Luo, Jian-Hua

Oncogenic Activity of miR-650 in Prostate Cancer Is Mediated by Suppression of CSR1 Expression

miR-650在前列腺癌中的致癌活性是通过抑制CSR1表达介导的。

Zuo, Ze-Hua; Yu, Yan P; Ding, Ying; Liu, Silvia; Martin, Amantha; Tseng, George; Luo, Jian-Hua

Discovery and Classification of Fusion Transcripts in Prostate Cancer and Normal Prostate Tissue

前列腺癌和正常前列腺组织中融合转录本的发现和分类

Luo, Jian-Hua; Liu, Silvia; Zuo, Ze-Hua; Chen, Rui; Tseng, George C; Yu, Yan P

Genomic Copy Number Variations in the Genomes of Leukocytes Predict Prostate Cancer Clinical Outcomes

白细胞基因组拷贝数变异可预测前列腺癌的临床结果

Yu, Yan P; Liu, Silvia; Huo, Zhiguang; Martin, Amantha; Nelson, Joel B; Tseng, George C; Luo, Jian-Hua

Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer

鉴定出转化性STRN-ALK融合基因是侵袭性甲状腺癌的潜在治疗靶点

Kelly, Lindsey M; Barila, Guillermo; Liu, Pengyuan; Evdokimova, Viktoria N; Trivedi, Sumita; Panebianco, Federica; Gandhi, Manoj; Carty, Sally E; Hodak, Steven P; Luo, Jianhua; Dacic, Sanja; Yu, Yan P; Nikiforova, Marina N; Ferris, Robert L; Altschuler, Daniel L; Nikiforov, Yuri E

Novel fusion transcripts associate with progressive prostate cancer

新型融合转录本与进展性前列腺癌相关

Yu, Yan P; Ding, Ying; Chen, Zhanghui; Liu, Silvia; Michalopoulos, Amantha; Chen, Rui; Gulzar, Zulfiqar G; Yang, Bing; Cieply, Kathleen M; Luvison, Alyssa; Ren, Bao-Guo; Brooks, James D; Jarrard, David; Nelson, Joel B; Michalopoulos, George K; Tseng, George C; Luo, Jian-Hua

Metallothionein 1 h tumour suppressor activity in prostate cancer is mediated by euchromatin methyltransferase 1

金属硫蛋白1在前列腺癌中的抑癌活性是由真染色质甲基转移酶1介导的。

Han, Yu-Chen; Zheng, Zhong-Liang; Zuo, Ze-Hua; Yu, Yan P; Chen, Rui; Tseng, George C; Nelson, Joel B; Luo, Jian-Hua